Image-Based Ultrasomics Classifiers: A Potential Method to Noninvasively Predict the Proliferation-Related Biomarker Ki67 [post]

anna yuan, Guoze Xu, Guiting Fang, Tong Li, Xiaomin Lai, Xing Zhong, Furong Huang
2020 unpublished
Objectives: The proliferation-related biomarker Ki67 is excellent in predicting the prognosis of breast cancer. 3D ultrasound imaging can provide information about coronal section images that help diagnose breast cancer. Our study aims to develop an ultrasomics method that extracts information related to Ki67 by analyzing the maximum transverse/sagittal/coronal section images of breast cancer mass. Methods: Our study retrospectively collected data on patients who had finished 3D ultrasound
more » ... 3D ultrasound examinations and were pathologically diagnosed with breast cancer. Images met the criteria were segmented, and then regions of interest (ROIs) were outlined for extracting ultrasomics features, such as statistical, morphological, texture, filter, and wavelet features.Results: The least absolute shrinkage and selection operator (LASSO) regression model selected 16 features that were closely related to the Ki67. The classification results of sensitivity, specificity, accuracy, and area under curve (AUC) of the transverse-sectional images were 0.6451, 0.8064, 0.7258, and 0.8065 (95% CI, 0.6915-0.9214), respectively; for sagittal-sectional images were 0.5806, 0.7741, 0.6774, and 0.6660 (95% CI, 0.5283-0.8037) respectively; for coronal-sectional images were 0.5806, 0.6774, 0.6290, and 0.7159 (95% CI, 0.5847-0.8471) respectively, and for a combination of three-section images were 0.7667, 0.7500, 0.7580, and 0.8510 (95% CI, 0.7537 -0.9483).Conclusions: The model classifier based on the transverse section images performed better than that based on the sagittal/coronal section images. The model classifier based on a combination of three-section images had a better outcome than that used only single section images. Image-based ultrasomics classifiers can noninvasively predict the Ki67 of breast cancer.
doi:10.21203/rs.3.rs-52480/v1 fatcat:h2jlcgrpjzc4db5nh3mqexchwq